Cytosorbents Corporation (CTSO)
NASDAQ · Healthcare
Cytosorbents Corporation EBITDA 2011–2025
Cytosorbents Corporation annual/quarterly ebitda history and growth rate from 2011 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Cytosorbents Corporation ebitda for the quarter ending March 31, 2025 was -3.5 M, a 17.36% decrease year-over-year.
- Cytosorbents Corporation ebitda for the twelve months ending March 31, 2025 was -23.0 M, a 88.64% increase year-over-year.
- Cytosorbents Corporation annual ebitda for 2025 was -13.5 M, a 10.60% decrease from 2024.
- Cytosorbents Corporation annual ebitda for 2024 was -15.1 M, a 50.42% decrease from 2023.
- Cytosorbents Corporation annual ebitda for 2023 was -30.5 M, a 0.49% decrease from 2022.
- Cytosorbents Corporation annual ebitda for 2022 was -30.6 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cytosorbents Corporation EBITDA — FAQ
Cytosorbents Corporation (CTSO) ebitda over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CTSO's ebitda history?
The chart and table above show Cytosorbents Corporation's ebitda by year and by quarter, including the growth rate.